Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer

R. Guerrero-Preston, C. Michailidi, L. Marchionni, CR. Pickering, MJ. Frederick, JN. Myers, S. Yegnasubramanian, T. Hadar, MG. Noordhuis, V. Zizkova, E. Fertig, N. Agrawal, W. Westra, W. Koch, J. Califano, VE. Velculescu, D. Sidransky,

. 2014 ; 9 (7) : 1031-46.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15014345

Tumor suppressor genes (TSGs) are commonly inactivated by somatic mutation and/or promoter methylation; yet, recent high-throughput genomic studies have not identified key TSGs inactivated by both mechanisms. We pursued an integrated molecular analysis based on methylation binding domain sequencing (MBD-seq), 450K Methylation arrays, whole exome sequencing, and whole genome gene expression arrays in primary head and neck squamous cell carcinoma (HNSCC) tumors and matched uvulopalatopharyngoplasty tissue samples (UPPPs). We uncovered 186 downregulated genes harboring cancer specific promoter methylation including PAX1 and PAX5 and we identified 10 key tumor suppressor genes (GABRB3, HOXC12, PARP15, SLCO4C1, CDKN2A, PAX1, PIK3AP1, HOXC6, PLCB1, and ZIC4) inactivated by both promoter methylation and/or somatic mutation. Among the novel tumor suppressor genes discovered with dual mechanisms of inactivation, we found a high frequency of genomic and epigenomic alterations in the PAX gene family of transcription factors, which selectively impact canonical NOTCH and TP53 pathways to determine cell fate, cell survival, and genome maintenance. Our results highlight the importance of assessing TSGs at the genomic and epigenomic level to identify key pathways in HNSCC, deregulated by simultaneous promoter methylation and somatic mutations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014345
003      
CZ-PrNML
005      
20241212093831.0
007      
ta
008      
150420s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.4161/epi.29025 $2 doi
035    __
$a (PubMed)24786473
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Guerrero-Preston, Rafael $u Department of Otolaryngology and Head and Neck Surgery; Johns Hopkins University; School of Medicine; Baltimore, MD USA; Department of Obstetrics and Gynecology; University of Puerto Rico School of Medicine; Río Piedras, Puerto Rico.
245    10
$a Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer / $c R. Guerrero-Preston, C. Michailidi, L. Marchionni, CR. Pickering, MJ. Frederick, JN. Myers, S. Yegnasubramanian, T. Hadar, MG. Noordhuis, V. Zizkova, E. Fertig, N. Agrawal, W. Westra, W. Koch, J. Califano, VE. Velculescu, D. Sidransky,
520    9_
$a Tumor suppressor genes (TSGs) are commonly inactivated by somatic mutation and/or promoter methylation; yet, recent high-throughput genomic studies have not identified key TSGs inactivated by both mechanisms. We pursued an integrated molecular analysis based on methylation binding domain sequencing (MBD-seq), 450K Methylation arrays, whole exome sequencing, and whole genome gene expression arrays in primary head and neck squamous cell carcinoma (HNSCC) tumors and matched uvulopalatopharyngoplasty tissue samples (UPPPs). We uncovered 186 downregulated genes harboring cancer specific promoter methylation including PAX1 and PAX5 and we identified 10 key tumor suppressor genes (GABRB3, HOXC12, PARP15, SLCO4C1, CDKN2A, PAX1, PIK3AP1, HOXC6, PLCB1, and ZIC4) inactivated by both promoter methylation and/or somatic mutation. Among the novel tumor suppressor genes discovered with dual mechanisms of inactivation, we found a high frequency of genomic and epigenomic alterations in the PAX gene family of transcription factors, which selectively impact canonical NOTCH and TP53 pathways to determine cell fate, cell survival, and genome maintenance. Our results highlight the importance of assessing TSGs at the genomic and epigenomic level to identify key pathways in HNSCC, deregulated by simultaneous promoter methylation and somatic mutations.
650    _2
$a aktivátorový protein specifický pro B-buňky $x genetika $x metabolismus $7 D051757
650    _2
$a spinocelulární karcinom $x genetika $x metabolismus $7 D002294
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a kohortové studie $7 D015331
650    _2
$a CpG ostrůvky $7 D018899
650    12
$a metylace DNA $7 D019175
650    _2
$a ženské pohlaví $7 D005260
650    12
$a umlčování genů $7 D020868
650    12
$a tumor supresorové geny $7 D016147
650    _2
$a nádory hlavy a krku $x genetika $x metabolismus $7 D006258
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mutace $7 D009154
650    _2
$a transkripční faktory paired box $x genetika $x metabolismus $7 D051761
650    12
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a receptor Notch1 $x genetika $x metabolismus $7 D051881
650    _2
$a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Michailidi, Christina $u Department of Otolaryngology and Head and Neck Surgery; Johns Hopkins University; School of Medicine; Baltimore, MD USA.
700    1_
$a Marchionni, Luigi $u Department of Oncology Biostatistics; Johns Hopkins University; School of Medicine; Baltimore, MD USA.
700    1_
$a Pickering, Curtis R $u Department of Head and Neck Surgery; University of Texas M.D. Anderson Cancer Center; Houston, TX USA.
700    1_
$a Frederick, Mitchell J $u Department of Head and Neck Surgery; University of Texas M.D. Anderson Cancer Center; Houston, TX USA.
700    1_
$a Myers, Jeffrey N $u Department of Head and Neck Surgery; University of Texas M.D. Anderson Cancer Center; Houston, TX USA.
700    1_
$a Yegnasubramanian, Srinivasan $u Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University; Baltimore, MD USA.
700    1_
$a Hadar, Tal $u Department of Otolaryngology and Head and Neck Surgery; Johns Hopkins University; School of Medicine; Baltimore, MD USA.
700    1_
$a Noordhuis, Maartje G $u Department of Otolaryngology and Head and Neck Surgery; Johns Hopkins University; School of Medicine; Baltimore, MD USA; Department of Otorhinolaryngology-Head and Neck Surgery; University of Groningen; University Medical Center; Groningen, The Netherlands.
700    1_
$a Zizkova, Veronika $u Department of Otolaryngology and Head and Neck Surgery; Johns Hopkins University; School of Medicine; Baltimore, MD USA; Laboratory of Molecular Pathology and Institute of Molecular and Translational Medicine; Faculty of Medicine and Dentistry; Palacky University; Olomouc, Czech Republic.
700    1_
$a Fertig, Elana $u Division of Biostatistics and Bioinformatics; Department of Oncology; Sidney Kimmel Comprehensive Cancer Center; Baltimore, MD USA.
700    1_
$a Agrawal, Nishant $u Department of Otolaryngology and Head and Neck Surgery; Johns Hopkins University; School of Medicine; Baltimore, MD USA; Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University; Baltimore, MD USA. $7 gn_A_00002267
700    1_
$a Westra, William $u Department of Otolaryngology and Head and Neck Surgery; Johns Hopkins University; School of Medicine; Baltimore, MD USA.
700    1_
$a Koch, Wayne M. $u Department of Otolaryngology and Head and Neck Surgery; Johns Hopkins University; School of Medicine; Baltimore, MD USA. $7 xx0326715
700    1_
$a Califano, Joseph $u Department of Otolaryngology and Head and Neck Surgery; Johns Hopkins University; School of Medicine; Baltimore, MD USA; Milton J. Dance Head and Neck Center; Greater Baltimore Medical Center; Baltimore, MD USA.
700    1_
$a Velculescu, Victor E $u Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University; Baltimore, MD USA.
700    1_
$a Sidransky, David $u Department of Otolaryngology and Head and Neck Surgery; Johns Hopkins University; School of Medicine; Baltimore, MD USA.
773    0_
$w MED00180218 $t Epigenetics. $x 1559-2308 $g Roč. 9, č. 7 (2014), s. 1031-46
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24786473 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20241212093824 $b ABA008
999    __
$a ok $b bmc $g 1071926 $s 897223
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 9 $c 7 $d 1031-46 $i 1559-2308 $m Epigenetics. $n Epigenetics $x MED00180218
LZP    __
$a Pubmed-20150420

Najít záznam

Citační ukazatele

Možnosti archivace